Sophora flavescens アイトンは,ROS/ MAPK/ 自殺反応の調節により,粒子状物質によって悪化した喘息を緩和する
Hoyeon Park1, Eom Ji Kim1, Eun-Young Kim1
1Department of Anatomy, College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Journal of ethnopharmacology
|August 24, 2025
まとめ
Sophora flavescens Aiton (SFA) は酸化ストレスと炎症を軽減することで,粒子状物質による喘息を効果的に治療します. 重要な信号伝達経路を調節し 喘息の悪化を治療する 可能性があるのです
科学分野:
- 薬理学 と 伝統 医学
- 免疫学と呼吸器疾患
- 細胞・分子生物学
背景:
- Sophora flavescens Aiton (SFA) は,伝統的に東アジアの医学で炎症性疾患に使用されています.
- 最近の研究では,SFAは抗喘息および抗炎症性があると示唆されています.
- 粒子状物質 (PM) でのSFAの正確なメカニズムはよく理解されていません.
研究 の 目的:
- SFAの抗炎症および抗喘息効果を調査する.
- PMで悪化した喘息のモデルでSFAの治療効果を評価する.
- 反応性酸素種 (ROS) に関する経路と炎症バイオマーカーのSFAの影響を明らかにする.
主な方法:
- In vitro: SFAで治療されたBEAS-2B細胞は,ROS,炎症,シグナリングを分析するためにTNF-α,IL-4およびPMにさらされます.
- in vivo:SFAで治療された卵白素に敏感なBalb/cマウスのPM加害性喘息モデル.
- 分析には血清IgE,肺炎マーカー,および組織病理学が含まれていた.
主要な成果:
- SFAは酸化ストレスと炎症誘発性サイトカインを in vitro と in vivo で有意に減少させた.
- SFAはMAPK (JNK,AKT) のリン酸化を抑制し,自己消化 (LC3発現) を調節した.
- in vivoでは,SFAは血清IgEを低下させ,肺の炎症誘発性サイトカインを抑制し,呼吸道滑らかな筋肉の厚さを低下させ,LC3II陽性領域を減少させた.
結論:
- SFAは,PMによって引き起こされる喘息の悪化に対して,重要な治療的可能性を示しています.
- SFAは,ROSの生成を抑制し,MAPK/オートファギーの経路を調節することにより,喘息を緩和します.
- SFAは,喘息のモデルにおける肺の組織病理学的特徴を改善する.
関連する概念動画
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
380
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
380